32 completed, 18 unknown, 6 terminated, 2 active not recruiting. 61 Phase 2, 16 Phase 3, 10 Phase 1.
Follow Wound Infection: new trials by email Literature Review of Wound Infection trials Research Report on Wound Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Use of Tranexamic Acid in Decreasing Wound Complication in Total Ankle Replacement. Transexamic acid, Normal Saline (0.9% NaCl) - Ankle Arthritis, Wound Complication | Phase 2 | Not yet recruiting | Ottawa Hospital Research Institute | 40 | 2026-12-01 | 2026-10-22 |
| Prophylactic Antibiotic in Subtalar Fusion Surgery Ceftriaxone 2000 mg - Surgical Site Infection | Phase 2 / Phase 3 | Unknown | Assiut University | 102 | 2024-09-01 | 2024-07-30 |
| Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers Antimicrobial Peptide PL-5 Topical Spray and Placebo - Diabetic Foot Ulcers | Phase 2 | Active not recruiting | Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | 90 | 2024-01-30 | 2025-05-25 |
| Multicenter Study Protocol: Research on Evaluation and Detection of Surgical Wound Complications with AI-based Recognition. (REDSCAR-trial) RedScar App - Surgical Wound Infection | Phase 2 / Phase 3 | Recruiting | Universitat de les Illes Balears | 168 | 2024-01-01 | 2025-01-20 |
| Small Bites Vs Large Bites Abdominal Midline Incisional Closure Small bite closure, Large bite closure - Suture Techniques, Wound Closure Techniques | Phase 2 / Phase 3 | Active not recruiting | Dow University of Health Sciences | 200 | 2023-11-23 | 2025-09-04 |
| Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® IMP, Placebo - Surgical Site Infection, Staphylococcus Aureus Infection | Phase 1 / Phase 2 | Unknown | MB PHARMA s.r.o. | 52 | 2023-10-27 | 2024-03-19 |
| Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies 0.9% saline solution, Povidone-iodine Swab - Surgical Site Infection, Surgical Wound | Phase 2 / Phase 3 | Recruiting | Dow University of Health Sciences | 200 | 2023-04-29 | 2025-06-18 |
| The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections Steri3X, Control - Surgical Site Infection, Cesarean Section; Complications, Wound, Infection (Following Delivery) | Phase 2 | Unknown | University of Tennessee | 1000 | 2023-02-07 | 2023-02-13 |
| Red Light Photobiomodulation and Topical Disinfectants Methylene Blue Only, Chlorhexidine Gluconate Only, Methylene Blue + Chlorhexidine Gluconate - Healthcare Associated Infection, Nosocomial Infection | Phase 1 / Phase 2 | Completed | Ondine Biomedical Inc. | 28 | 2023-01-10 | 2023-04-04 |
| Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection. Honey Dressing, Iodine Dressing - Wound Infection, Wound Dehiscence | Phase 2 / Phase 3 | Completed | HITEC-Institute of Medical Sciences | 80 | 2022-12-02 | 2024-01-25 |
| Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection | Phase 2 | Completed | Ondine Biomedical Inc. | 322 | 2022-02-04 | 2022-08-22 |
| Phage Therapy for the Prevention and Treatment of Pressure Ulcers. Bacteriophage-loaded Microcapsule Spray, Placebo, Standard of Care - Pressure Ulcer | Phase 1 / Phase 2 | Unknown | Precisio Biotix Therapeutics, Inc. | 69 | 2022-01-01 | 2021-12-21 |
| Tumescent Anesthesia Antibiotic Delivery (TAAD) Tumescent Anesthesia and antibiotic delivery (TAAD) plus IVAD, SubQKath - Surgical Site Infection, Thrombosis | Phase 2 / Phase 3 | Unknown | HK Surgical, Inc. | 330 | 2021-12-01 | 2021-02-02 |
| Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery Cefuroxime (Zinnat®), Ceftriaxone (Rocephin®) - Surgical Site Infection, Antibiotics Prophylaxis | Phase 2 | Completed | Dr. Promise Tamunoipiriala Jaja | 96 | 2021-12-01 | 2023-05-26 |
| NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies Negative Pressure Wound Therapy - Surgical Wound Infection | Phase 2 / Phase 3 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 290 | 2021-08-05 | 2026-06-09 |
| Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery Oral Sulfate Tablet(ORA·FANGⓇ), Sodium Picosulfate Solution(PicosolutionⓇ) - Colorectal Cancer | Phase 2 | Unknown | National Cancer Center, Korea | 414 | 2020-11-01 | 2020-10-20 |
| Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis Chlorhexidine Gluconate vaginal solution 0.05% - Postpartum Endometritis, Wound Infection | Phase 1 / Phase 2 | Completed | Zagazig University | 840 | 2020-05-15 | 2022-09-23 |
| Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis Topical vancomycin paste (1g vancomycin powder + 4mL sterile saline) and Collatamp G gentamicin-eluting sponge (Azralez Pharmaceuticals; 2.0mg gentamicin sulphate/cm2 to cover wound) - Vascular Diseases, Peripheral Vascular Disease | Phase 2 / Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 356 | 2020-05-01 | 2020-01-30 |
| Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion Vancomycin - Surgical Site Infection | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 450 | 2019-10-15 | 2026-08-05 |
| Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection | Phase 2 | Unknown | RWJ Barnabas Health at Jersey City Medical Center | 800 | 2019-09-15 | 2019-09-17 |
Showing 20 of 61. Sign in to see all of them.
Surgical Wound Infection (40) · Cellulitis (6) · Cross Infection (6) · Abscess (5) · Infections (5) · Staphylococcal Infections (5) · Bacterial Infections (4) · Burns (4) · Wounds and Injuries (4) · Gram-Positive Bacterial Infections (3) · Colorectal Neoplasms (2) · Peripheral Vascular Diseases (2) · Pseudomonas Infections (2) · Sepsis (2)
Infections (56) · Pathologic Processes (46) · Pathological Conditions, Signs and Symptoms (46) · Postoperative Complications (40) · Bacterial Infections and Mycoses (9) · Inflammation (9) · Skin and Connective Tissue Diseases (8) · Connective Tissue Diseases (6) · Disease Attributes (6) · Iatrogenic Disease (6) · Suppuration (6) · Bacterial Infections (5) · Cardiovascular Diseases (5) · Gram-Positive Bacterial Infections (5)
Vancomycin (5) · Ethanol (4) · Povidone-Iodine (4) · chlorhexidine gluconate (4) · Saline Solution (3) · Sodium Chloride (3) · Ceftriaxone (2) · Cefuroxime (2) · Chlorhexidine (2) · Chromogranins (2) · Linezolid (2) · Metronidazole (2) · Negative-Pressure Wound Therapy (2) · Standard of Care (2) · cefuroxime axetil (2)
Assiut University (2) · Cumberland Pharmaceuticals (2) · Dow University of Health Sciences (2) · Dr. Reddy's Laboratories Limited (2) · National Cancer Center, Korea (2) · Ondine Biomedical Inc. (2) · University Hospital, Geneva (2) · Washington University School of Medicine (2) · Zurex Pharma, Inc. (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Affinium Pharmaceuticals, Ltd (1) · Ain Shams Maternity Hospital (1) · Angela Bianco (1) · Attabib, Najmedden, M.D. (1) · Cellceutix Corporation (1)
United States (27) · Canada (5) · Pakistan (3) · South Korea (3) · Switzerland (3) · Egypt (2) · France (2) · Belgium (1) · Brazil (1) · China (1) · Colombia (1) · Czechia (1) · Georgia (1) · Hungary (1) · Israel (1)
G. Ralph Corey, MD (2) · Adam Power, MD (1) · Ahmed Shafiek (1) · Akiva P Novetsky, MD, MS (1) · Alain Vonlaufen, MD (1) · Amos O Adeleye, FWACS, FACS (1) · AnaMaria Garza, MD (1) · Andrew Kirby (1) · Angela Bianco, MD (1) · Augustine A Adeolu, FWACS (1) · Avery B Nathens, MD PhD MPH (1) · Barry Hafkin, MD (1) · Bradley Meulenkamp, MD MSc FRCSC (1) · Chris Beausoleil (1)
PMID 32335895, PMID 32580252, PMID 40260835, PMID 10219875, PMID 12573039, PMID 15855756, PMID 16980879, PMID 17076839, PMID 17119142, PMID 17588420, PMID 18338205, PMID 18461895, PMID 18560962, PMID 18636300, PMID 19231586, PMID 19276766, PMID 20878941, PMID 21475006, PMID 22297835, PMID 25631195, PMID 26229155, PMID 26537879, PMID 26711777, PMID 27313846, PMID 27899130, PMID 28594761, PMID 28656047, PMID 28865981, PMID 30292481, PMID 30519893, PMID 33345865, PMID 36951472, PMID 38022210, PMID 40993807, PMID 41159585, PMID 7925666
2019 (1), P50HL073996 (1), R44AR047499 (1)